On October 31, 2022, Helix BioPharma Corp. closed the transaction. The transaction included participation from directors and insiders for CAD 270,000 of the company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.205 CAD | -2.38% | -2.38% | -2.38% |
Apr. 08 | Helix BioPharma Corp. announced that it has received CAD 1.915 million in funding | CI |
Mar. 28 | Helix BioPharma Corp. announced that it expects to receive CAD 1.915 million in funding | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.38% | 34.37M | |
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- HBP Stock
- News Helix BioPharma Corp.
- Helix BioPharma Corp. announced that it has received CAD 4.62902 million in funding